Sicart Associates LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001696494

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHigh Turnover how tags are computed

Q2 2026 · 74 positions · Total reported value $408.40M · Top-10 concentration 51.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 41.8% · 5 new · 22 cut · 6 exited

Active Share (vs S&P 500): 84.4% · vs QQQ: 85.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -1.8% · vs SPY -3.9% · Prev Value $408.40M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.2% · vs SPY -3.4% · Latest Value $412.55M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2026 13F filing, Sicart Associates LLC disclosed 74 equity positions with a combined reported value of $408.40M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 51.0% of reported value. HoldingsHub classifies the profile as Small / High Turnover.

The largest disclosed positions as of Q2 2026 were BIL ($34.93M), GH ($34.66M), GLD ($29.80M). By sector, the heaviest allocations are Health Care 18.3%, Technology 14.1%. Versus the prior quarter, allocation shifted toward Materials (+6.3pp), Health Care (+3.5pp) and away from Financials (-2.0pp), Consumer Discretionary (-2.6pp).

Versus the prior quarter, Sicart Associates LLC opened 5 new positions, trimmed 22 and fully exited 6, a turnover rate of 41.8% of positions. The portfolio's overlap with the prior quarter was 90% of names.

The largest new positions opened in Q2 2026 were ORCL ($7.12M), SNOW ($256.03K), ROK ($235.16K).

Of the 6 positions fully exited versus the prior quarter, the largest were KHC ($2.47M), CLX ($1.50M), CPB ($347.63K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • ORCL ORACLE CORP · $7.12M
  • SNOW SNOWFLAKE INC · $256.03K
  • ROK ROCKWELL AUTOMATION INC · $235.16K
  • PTCT PTC THERAPEUTICS INC · $223.91K

Fully Exited (vs previous quarter)

  • KHC KRAFT HEINZ CO · prev qtr: $2.47M
  • CLX CLOROX CO DEL · prev qtr: $1.50M
  • CPB THE CAMPBELL'S COMPANY · prev qtr: $347.63K
  • GDX VANECK ETF TRUST · prev qtr: $220.71K

Insider Transactions (Form 4)

Latest Sicart Associates LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Sicart Associates LLC, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 74 positions worth $408.40M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-108418 (status: Approved), registered 2016-09-29
  • Regulatory AUM (Form ADV): $455.38M as of 2026-04-07
  • Client mix (by RAUM): individual investors 95%, pension and profit-sharing plans 5%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 74 positions · $408.40M reported value (Q2 2026)
  • Top 10 holdings = 51.0% of reported value
  • Largest position: BIL (SPDR SERIES TRUST) at 8.6%
  • Average position size: $5.52M

Sector Tilt

  • Health Care 18.3%
  • Information Technology 14.1%
  • Consumer Discretionary 12.7%
  • (classified holdings cover 81% of value)

Quarterly Activity

  • Q2 2026: 4 new, 8 added, 21 reduced, 4 exited
  • 41 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 18.3%
Technology 14.1%
Industrials 10.8%
Financials 9.9%
Materials 6.3%
Utilities 3.5%
Other 24.3%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 381.18K $34.93M 8.55%
8.55%
Reduce
2 231.01K $34.66M 8.49%
8.49%
Hold
3 80.90K $29.80M 7.30%
7.30%
Reduce
4 50.88K $21.40M 5.24%
5.24%
Add
5 47.15K $16.85M 4.13%
4.13%
Reduce
6 277.88K $15.56M 3.81%
3.81%
Add
7 83.13K $14.62M 3.58%
3.58%
Hold
8 53.02K $14.22M 3.48%
3.48%
Hold
9 93.25K $13.34M 3.27%
3.27%
Hold
10 160.69K $12.74M 3.12%
3.12%
Add
11 166.41K $11.88M 2.91%
2.91%
Add
12 124.67K $11.79M 2.89%
2.89%
Hold
13 121.83K $10.53M 2.58%
2.58%
Reduce
14 1.17M $9.91M 2.43%
2.43%
Add
15 114.42K $9.56M 2.34%
2.34%
Hold
16 108.89K $9.00M 2.20%
2.20%
Reduce
17 185.22K $8.61M 2.11%
2.11%
Hold
18 40.36K $8.27M 2.03%
2.03%
Hold
19 14.53K $8.18M 2.00%
2.00%
Hold
20 105.21K $8.00M 1.96%
1.96%
Hold
21 48.56K $7.12M 1.74%
1.74%
New
22 78.20K $6.88M 1.68%
1.68%
Add
23 58.65K $6.26M 1.53%
1.53%
Reduce
24 23.65K $6.04M 1.48%
1.48%
Reduce
25 44.52K $6.01M 1.47%
1.47%
Reduce
26 71.92K $5.63M 1.38%
1.38%
Reduce
27 80.67K $5.08M 1.24%
1.24%
Hold
28 49.99K $4.81M 1.18%
1.18%
Reduce
29 206.06K $4.37M 1.07%
1.07%
Add
30 14.92K $4.32M 1.06%
1.06%
Reduce
31 6.91K $4.31M 1.05%
1.05%
Reduce
32 11.47K $4.28M 1.05%
1.05%
Hold
33 71.18K $3.81M 0.93%
0.93%
Hold
34 46.35K $3.77M 0.92%
0.92%
Reduce
35 39.33K $3.36M 0.82%
0.82%
Hold
36 8.51K $2.66M 0.65%
0.65%
Reduce
37 5.00K $2.50M 0.61%
0.61%
Add
38 106.22K $2.20M 0.54%
0.54%
Reduce
39 19.39K $1.98M 0.48%
0.48%
Reduce
40 47.63K $1.96M 0.48%
0.48%
Hold
41 25.00K $1.78M 0.43%
0.43%
Hold
42 89.70K $1.69M 0.41%
0.41%
Reduce
43 12.15K $1.39M 0.34%
0.34%
Hold
44 4.69K $1.03M 0.25%
0.25%
Hold
45 10.74K $819.17K 0.20%
0.20%
Reduce
46 5.00K $723.05K 0.18%
0.18%
Hold
47 2.79K $664.25K 0.16%
0.16%
Hold
48 4.32K $632.91K 0.15%
0.15%
Hold
49 5.57K $631.20K 0.15%
0.15%
Hold
50 2.15K $581.17K 0.14%
0.14%
Reduce

FAQ

What did Sicart Associates LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, Sicart Associates LLC reported 74 equity positions worth $408.40M in aggregate; its largest disclosed positions were BIL ($34.93M), GH ($34.66M), GLD ($29.80M).

How large is Sicart Associates LLC's portfolio?

Sicart Associates LLC reported $408.40M of long equity holdings across 74 positions as of 2026-Q2. Top-10 holdings account for 51.0% of reported value.

What is Sicart Associates LLC's investment style?

HoldingsHub classifies the portfolio as Small / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sicart-associates/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →